OpenAI recently invested $250 million in Merge Labs, a startup innovating in brain-computer interface (BCI) technology. Merge Labs distinguishes itself with a non-invasive ultrasound method that connects directly to brain activity without surgical intervention, unlike competitors such as Neuralink. This groundbreaking approach aims to enhance rehabilitation and assistive technologies for paralyzed individuals. According to OpenAI, BCIs promise to revolutionize communication and interaction with artificial intelligence (AI), fostering a more natural relationship between humans and technology. Future applications could extend beyond medical patients to healthy individuals, potentially allowing users to control AI applications through thought alone. Merge Labs, which gained attention in August 2025, has now reached a valuation of approximately $850 million, with participation from notable investors like Bain Capital and Valve CEO Gabe Newell. This investment highlights the significant potential of non-invasive BCI technology in shaping the future of human-AI interaction.
Source link
